The National Heart Institute (IJN) today announced it has successfully implanted the world’s first dual-chamber leadless pacemaker system, the Abbott AVEIR™ DR, on several of its patients.

P ETALING JAYA: The National Heart Institute (IJN) today announced it has successfully implanted the world’s first dual-chamber leadless pacemaker system, the Abbott AVEIR DR, on several of its ...

Unlike traditional pacemakers, it consists of two miniaturised devices, each one-tenth the size of conventional models, implanted directly into the heart’s right atrium and ventricle. As the world’s ...

Unlike traditional pacemakers, it consists of two miniaturised devices, each one-tenth the size of conventional models, implanted directly into the heart’s right atrium and ventricle. As the world’s ...

The Aveir dual-chamber leadless pacemaker [Image courtesy of Abbott] Abbott (NYSE: ABT) + published findings from the AVEIR DR i2i study evaluating the company’s novel dual-chamber leadless ...

Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction ...

Tuesday, June 17, 2025. News & Perspective Drugs & Diseases CME & Education Video Decision Point Drugs & Diseases CME & Education Video Decision Point ...

Traditional pacemakers have one or more leads that are placed in the atrium (upper chamber) or ventricle (lower chamber), or in some cases both based on the patients’ medical condition.

We aim to explore how these factors, along with left atrial diameter (LAD), contribute to AF development, providing insights into optimizing pacemaker settings to potentially reduce AF risk in ...